Pharmaceutical composition
    1.
    发明授权
    Pharmaceutical composition 有权
    药物组成

    公开(公告)号:US09034821B2

    公开(公告)日:2015-05-19

    申请号:US14111072

    申请日:2012-04-13

    CPC分类号: A61K47/38 A61K38/08 A61K38/11

    摘要: The present invention relates to a novel pharmaceutical composition comprising oxytocin and/or one or more fragment(s) and/or variant(s) thereof and at least one non-ionic cellulose ether, such as hydroxypropylmethylcellulose, said pharmaceutical composition having a low pH. The present pharmaceutical composition has been shown to provide an exceptionally suitable environment for oxytocin, as the stability thereof has increased significantly as compared to previous compositions with this molecule. The pharmaceutical composition according to the invention can be used for medical purposes, such as in the treatment of climacteric disorders.

    摘要翻译: 本发明涉及包含催产素和/或其一个或多个片段和/或其变体和至少一种非离子纤维素醚(例如羟丙基甲基纤维素)的新型药物组合物,所述药物组合物具有低pH 。 已经显示出本发明的药物组合物为催产素提供了非常合适的环境,因为与先前使用该分子的组合物相比,其稳定性显着增加。 根据本发明的药物组合物可用于医疗目的,例如治疗更年期疾病。

    Use
    2.
    发明申请
    Use 审中-公开
    使用

    公开(公告)号:US20060234919A1

    公开(公告)日:2006-10-19

    申请号:US10488166

    申请日:2002-09-02

    IPC分类号: A61K38/22

    CPC分类号: A61K38/095

    摘要: The present invention relates to the use of substances with oxytocin for the preparation of pharmaceutical composition against inflamation. It also relates to a pharmaceutical composition comprising at least one substance with oxytocin activity against inflamation.

    摘要翻译: 本发明涉及具有催产素的物质用于制备抗炎症药物组合物的用途。 它还涉及一种药物组合物,其包含至少一种具有抵抗炎症的催产素活性的物质。

    Use of substances with oxytocin activity against climacteric disorders
    3.
    发明授权
    Use of substances with oxytocin activity against climacteric disorders 有权
    使用具有催产素活性的物质对更年期疾病

    公开(公告)号:US07727959B2

    公开(公告)日:2010-06-01

    申请号:US11345218

    申请日:2006-02-02

    IPC分类号: A61K38/11

    CPC分类号: A61K38/11 A61K2300/00

    摘要: The present invention relates to the use of substances with oxytocin activity against climacteric disorders or similar symptoms due to dysfunction in the ovaries. It also relates to a pharmaceutical composition comprising at least one substance with oxytocin activity against climacteric disorders.

    摘要翻译: 本发明涉及具有催产素活性的物质对由于卵巢功能障碍引起的更年期病症或类似症状的用途。 它还涉及包含至少一种具有催产素活性的物质与更年期病症的药物组合物。